<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04178772</url>
  </required_header>
  <id_info>
    <org_study_id>CR-5945</org_study_id>
    <nct_id>NCT04178772</nct_id>
  </id_info>
  <brief_title>Characterizing Successful Myopic Multifocal Contact Lens Wearers</brief_title>
  <official_title>Characterizing Successful Myopic Multifocal Contact Lens Wearers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a prospective, single group, single-arm, and bilateral dispensing study.
      Subjects will be assigned to a single study lens type to be worn bilaterally in daily wear,
      and daily disposable modality, for at least 6 hours per day every day for approximately 12
      weeks.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    To ensure the safety of participants during the COVID-19 pandemic, this clinical trial is
    suspended until further notice
  </why_stopped>
  <start_date type="Actual">November 4, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Likely to be Successful Group</measure>
    <time_frame>up to 12- week follow-up</time_frame>
    <description>The successful lens wear will be converted to a binary response where 1 = successful lens wear, and 0 = unsuccessful lens wear.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quest Questionnaire Classification</measure>
    <time_frame>at Baseline</time_frame>
    <description>Subject will answer a series of questions including Contact Lens Wear History, Occupation Hobbies, Visual Demands, Contact lens Success, Reasons for Success / Failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Auto-refraction &amp; keratometry (Autorefractor)</measure>
    <time_frame>at Baseline</time_frame>
    <description>Subjects will have their right eye and left eye measured in diopters (0.125 steps).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refraction including reading addition (Phoropter)</measure>
    <time_frame>at Baseline</time_frame>
    <description>The near reading addition will be determined using the binocular crossed cylinder technique at 40 cm followed by optimization in a trial frame. The measurement will be recorded in Diopters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LogMAR (Logarithm of Minimal Angle of resolution) Visual Acuity: monocular &amp; binocular - distance (4m)</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Subjects will have their visual acuity tested on their right eye (occluding the left eye), the left eye (occluding the right eye), and both eyes together from a distance of 4m using logMAR visual acuity charts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LogMAR (Logarithm of Minimal Angle of resolution) Visual Acuity: monocular &amp; binocular - near (40 cm)</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Subjects will have their visual acuity tested on their right eye (occluding the left eye), the left eye (occluding the right eye), and both eyes together from a distance of 40 cm using logMAR visual acuity charts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LogMAR (Logarithm of Minimal Angle of resolution) Visual Acuity: monocular &amp; binocular - intermediate (1 m)</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Subjects will have their visual acuity tested on their right eye (occluding the left eye), the left eye (occluding the right eye), and both eyes together from a distance of 1m using logMAR visual acuity charts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance (4m) Fixation Disparity (with refraction)</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Subjects will be tested to measure horizontal amount of prism in vision. Fixation disparity will be recorded from 1m distance and will be recorded in Diopters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Near (40cm) Fixation Disparity (with refraction)</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Subjects will be tested to measure horizontal amount of prism in vision. Fixation disparity will be recorded from 40cm distance and will be recorded in Diopter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blur tolerance (with refraction): binocular, distance only</measure>
    <time_frame>at Baseline</time_frame>
    <description>Subjects will be positioned in front of a 1m screen where two tests will be performed to indicate when the image on the screen becomes absolutely intolerable and then when the image is just tolerable. The average of the two thresholds will be the 'objectionable blur threshold' and will be recorded in Diopters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stereo-acuity: near (40 cm)</measure>
    <time_frame>at Baseline</time_frame>
    <description>Subjects wearing Polaroid lenses will view a Randot stereo book at 40 cm and indicate which circle appears to be different from the others. The endpoint of the test is when there are two consecutive incorrect responses. The score is the box in which the last correct response was made. The value is recorded in seconds of arc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast threshold: OD. OS, and OU distance only:</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Subject will read letters from a fixed target, 2.4 m distance, first occluding the left eye, then occluding the right eye, and then both eyes together. The subject will continue to read letters as the illumination contrast is reduced. Once the subject identifies few or 0 letters, the contrast threshold will be measured for each eye and both eyes together.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupil size: Photopic; OD &amp; OS, distance</measure>
    <time_frame>up to 1-week follow-up</time_frame>
    <description>In bright light, the diameter of the subject's pupil will be measured with a pupillometer one at a time, in mm, at a distance of 4m.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupil size: Photopic; OD &amp; OS, Intermediate</measure>
    <time_frame>up to 1-week follow-up</time_frame>
    <description>In bright light, the diameter of the subject's pupil will be measured with a pupillometer one at a time, in mm, at a distance of 1m</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupil size: Photopic; OD &amp; OS, near</measure>
    <time_frame>up to 1-week follow-up</time_frame>
    <description>In bright light, the diameter of the subject's pupil will be measured with a pupillometer one at a time, in mm, at a distance of 40cm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupil size: Scotopic; OD &amp; OS, distance</measure>
    <time_frame>up to 1-week follow-up</time_frame>
    <description>In dim light, the diameter of the subject's pupil will be measured with a pupillometer one at a time, in mm, at a distance of 4m</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupil size: Scotopic; OD &amp; OS, Intermediate</measure>
    <time_frame>up to 1-week follow-up</time_frame>
    <description>In dim light, the diameter of the subject's pupil will be measured with a pupillometer one at a time, in mm, at a distance of 1m</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupil size: Scotopic; OD &amp; OS, near</measure>
    <time_frame>up to 1-week follow-up</time_frame>
    <description>In dim light, the diameter of the subject's pupil will be measured with a pupillometer one at a time, in mm, at a distance of 40cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-invasive tear break-up time (NITBUT): OD &amp; OS (Placido disc):</measure>
    <time_frame>at Baseline</time_frame>
    <description>NITBUT will be measured and recorded with Placido disc topographer projecting onto pre-lens tear film for each eye. 3 separate measurements will be collected and a mean of the three measurements will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective accommodation with distance refraction (WAM 5500: 4 m, 1 m, and 40 cm target) OD &amp; OS</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Objective accommodation will be recorded using WAM 5500 refractometer for 4m, 1m, and 40cm targets with the contact lenses in each eye. The average for each distance measurement for each eye will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spherical aberration OD &amp; OS</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Spherical aberrations will be measured using the Complete Ophthalmic Analysis System (COAS), 2 seconds after blink for each eye at distance target Coma (Comatic Abberation)over the Contact lenses. The aberrometer will measure the distortion in microns.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COAS (wavefront measurements), 2 secs after blink, OD &amp; OS @ distance target:</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>igher order aberrations will be measured with a wavefront aberrometer that measures the distortion of a light wave as it is altered by passing through the optics of the eye. The aberrometer will measure the distortion in microns from a 4m distance for each eye.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coma(Comatic Abberations)</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Comatic aberrations will be measured with a wavefront aberrometer that measures the distortion of a light wave as it is altered by passing through the optics of the eye. The aberrometer will measure the distortion in microns at a 4m distance for each eye.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other higher order aberrations</measure>
    <time_frame>up to 12-week follow-up</time_frame>
    <description>Higher order aberrations will be measured with a wavefront aberrometer that measures the distortion of a light wave as it is altered by passing through the optics of the eye. The aberrometer will measure the distortion in microns at a 4m distance for each eye.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens centration OD &amp; OS</measure>
    <time_frame>at Baseline</time_frame>
    <description>Corneal topography will be performed to estimate the contact lens centration on each eye. The lens centration will be measured from the center of the placido disk reflections to the center of the contact lens in mm.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>JJVC Marketed Contact Lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eligible subjects that have no experience with soft multifocal lenses for more than 2 years will be assigned to a single study lens type worn in both eyes daily for at least 6 hours per day, everyday for approximately 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acuvue Moist Multifocal Contact Lens JJVC Marketed Contact Lens</intervention_name>
    <description>JJVC Marketed Contact Lens</description>
    <arm_group_label>JJVC Marketed Contact Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Potential Subjects must satisfy all of the following criteria to be enrolled in the
             study:

               1. The participant must read, understand, and sign the STATEMENT OF INFORMED CONSENT
                  and receive a fully executed copy of the form.

               2. Appear able and willing to adhere to the instructions set forth in this clinical
                  protocol.

               3. Is at least 40 years of age (inclusive) at the time of screening and has full
                  legal capacity to volunteer.

               4. Had a self-reported eye examination in the last two years.

               5. The subject must either already be wearing a presbyopic correction (e.g., reading
                  spectacles over contact lenses, or multifocal spectacles, etc.) or respond
                  positively to at least one symptom on the 'Presbyopic Symptoms Questionnaire&quot;.

               6. Can achieve best corrected distance monocular visual acuity of at least +0.20
                  logMAR and binocular visual acuity of at least +0.10 logMAR with refraction.

               7. Have a refractive cylinder of ≤1.00 D in each eye.

               8. Has corrected best sphere equivalent distance refraction in the range -1.25 D of
                  -3.75 D in each eye.

               9. Have a reading ADD power in the range of +0.75 D to +1.75 D (inclusive) in each
                  eye.

              10. Have a wearable pair of spectacles (at the discretion of the investigator) to
                  wear when they cannot wear the study lenses.

                  Exclusion Criteria:

          -  Potential Subjects who meet any of the following criteria will be excluded from
             participating in the study:

               1. Participation in any contact lens or lens care clinical trial within 1 week prior
                  to study enrollment.

               2. Employee or immediate family member of an employee of the Centre for Ocular
                  Research &amp; Education listed on the study Delegation Log (e.g., Investigator,
                  Coordinator, Technician).

               3. Is currently pregnant or lactating, by self-report, or planning a pregnancy at
                  the time of enrollment.

               4. Has any known active ocular disease and/or allergies, ocular infections or other
                  abnormalities that are known to interfere with contact lens wear (at the
                  discretion of the investigator). This may include, but not be limited to
                  entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of
                  recurrent corneal erosions, or corneal distortion.

               5. Is using any topical ocular medications other than lubricating eye drops.

               6. Known to have any infectious disease (e.g., hepatitis, tuberculosis) or a
                  contagious immunosuppressive disease.

               7. Have any systemic disease, autoimmune disease, or use of medication, which may
                  interfere with contact lens wear (at the discretion of the investigator). This
                  may include, but not be limited to, hyperthyroidism, recurrent herpes
                  simplex/zoster, Sjogren's syndromes, xerophthalmia, acne rosacea, Stevens-Johnson
                  syndromes.

               8. Had a diagnosis of a condition known to affect ocular prescription or ocular
                  surface or tear film e.g., rheumatoid arthritis, diabetes.

               9. Had a change within the previous 3 months to the dosage of a systemic medication
                  known to affect ocular prescription or ocular surface or tear film (e.g.,
                  steroids) that in the opinion of the investigator may affect a study outcome
                  variable.

              10. Has undergone cataract or refractive error surgery (e.g., radial keratotomy, PRK,
                  LASIK, etc.), or has any planned (during the study) major surgery (e.g. hip
                  replacement), or any planned ocular surgery (e.g. cataract or refractive error
                  surgery).

              11. Is a current rigid contact lens wearer, or is wearing contact lenses on extended
                  wear basis, or has a history of extended wear in the past 6 months.

              12. Has worn soft MF CLs in the past 2 years or is a habitual wearer of monovision
                  CLs.

              13. Has a constant unilateral strabismus at both far and near distances, or has
                  anisometropia &gt;2 D between both eyes, or has amblyopia.

              14. Has a known sensitivity to the diagnostic pharmaceuticals to be used in the study
                  (Refresh Plus® rewetting drop solution, Sodium Fluorescein or Alcon Clear Care
                  Cleaning System).

              15. Has any Grade 3.0 or greater slit lamp findings (e.g., edema, corneal
                  neovascularization, corneal staining, tarsal abnormalities, conjunctival
                  injection) on the biomicroscopy classification scale, any previous history or
                  signs of a contact lens-related corneal inflammatory event (e.g., past peripheral
                  ulcer or round peripheral scar), or any other ocular abnormality that may
                  contraindicate contact lens wear (at the discretion of the investigator).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre for Ocular Research and Education, University of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 25, 2019</study_first_submitted>
  <study_first_submitted_qc>November 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

